65057-97-8

Usage

Uses

Used in Pharmaceutical Industry:
2-(dimethoxymethyl)tetrahydro-2,5-dimethoxyfuran is utilized as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable building block in the development of new drugs with enhanced bioactivity and therapeutic potential.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-(dimethoxymethyl)tetrahydro-2,5-dimethoxyfuran serves as a key compound for studying the structure-activity relationships of potential drug candidates. Its incorporation into drug molecules can lead to the discovery of new therapeutic agents with improved efficacy and safety profiles.
Used in Drug Discovery:
2-(dimethoxymethyl)tetrahydro-2,5-dimethoxyfuran is employed as a starting material in the drug discovery process. Its chemical versatility allows for the exploration of various synthetic pathways and the generation of diverse drug candidates with potential applications in the treatment of various diseases and conditions.

InChI:InChI=1/C9H18O5/c1-10-7-5-6-9(13-4,14-7)8(11-2)12-3/h7-8H,5-6H2,1-4H3

Upstream product

• 1708-41-4 2-(furan-2-yl)-1,3-dioxolane 
• 59906-91-1 2,5-dihydro-2,5-dimethoxy-2-furaldehyde dimethyl acetal 

Downstream Products

• 1262333-07-2 1-(3,4-dimethoxybenzyl)-1,2,3,4,5,12b-hexahydropyrrolo-[2',1':3,4]pyrazino[1,2-a][1,3]diazepin-7(8H)-one 
• 1262333-06-1 1-benzyl-1,2,3,4,5,12b-hexahydropyrrolo[2',1':3,4]pyrazino[1,2-a][1,3]diazepin-7(8H)-one 
• 1262333-05-0 3,3-dimethyl-1-(3,4-dimethoxybenzyl)-1,3,4,11b-tetrahydro-2H-pyrrolo[2',1':3,4]pyrazino[1,2-a]pyrimidin-6(7H)-one 
• 1262333-02-7 1-(3,4-dimethoxybenzyl)-1,3,4,11b-tetrahydro-2H-pyrrolo-[2',1':3,4]-pyrazino[1,2-a]pyrimidin-6(7H)-one 
• 1262332-93-3 1-(3,4,5-trimethoxybenzyl)-1,2,3,10b-tetrahydroimidazo-[1,2-a]pyrrolo[2,1-c]pyrazin-5(6H)-one 
• 1262332-92-2 1-(3,4-dimethoxybenzyl)-1,2,3,10b-tetrahydroimidazo[1,2-a]-pyrrolo[2,1-c]pyrazin-5(6H)-one 
• 1262332-91-1 1-benzyl-1,2,3,10b-tetrahydroimidazo[1,2-a]pyrrolo[2,1-c]-pyrazin-5(6H)-one 
• 1095361-88-8 ethyl 2-(2-formyl-1H-pyrrol-1-yl)benzenecarboxylate 
• 79100-16-6 methyl 2-(2-formyl-1H-pyrrol-1-yl)benzenecarboxylate 
• 1095361-90-2 methyl 4,5-dimethoxy-2-(2-formyl-1H-pyrrol-1-yl)benzenecarboxylate 
• 1095362-25-6 C₂₄H₂₈N₂O₄ 
• 1095362-22-3 C₂₂H₂₄N₂O₂ 
• 1095362-19-8 C₂₀H₂₀N₂ 
• 1095362-30-3 5-(3,4-dimethoxybenzyl)-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzodiazepine 

Relevant academic research and scientific papers

On the formation of reductic acid from pentoses or hexuronic acids

Careful hydrolysis of (±)-cis- or (±)-trans-tetrahydro-2,5-dimethoxy-2-furaldehyde dimethyl acetal proceeded via 5,5-dimethoxy-4-oxopentanal to give (±)-trans-4-hydroxy-5-methoxy-2-cyclopenenone and (±)-trans-4,5-dihydroxy-2-cylopentenone. The latter product did not isomerize to 2,3-dihydroxy-2-cyclopentenone (reductic acid) on prolonged reaction. Careful hydrolysis of (±)-cis- or (±)-trans-tetrahydro-2, 5-dimethoxy-2-furaldehyde dimethyl acetal proceeded via 5, 5-dimethoxy-4-oxopentanal to give (±)-tran-4-hydroxy-5-methoxy-2-cyclopentenone and (±)-trans-4 ,5-dihydroxy-2-cyclopentenone. The latter product did not isomerize to 2,3-dihydroxy-2-cyclopentenone (reductic acid) on prolonged reaction.